首页 | 本学科首页   官方微博 | 高级检索  
检索        

RVO黄斑水肿患者雷珠单抗治疗后脉络膜厚度的变化
引用本文:张祺,冯劼,李培凤,金翼,陈思敏.RVO黄斑水肿患者雷珠单抗治疗后脉络膜厚度的变化[J].国际眼科杂志,2015,15(4):712-713.
作者姓名:张祺  冯劼  李培凤  金翼  陈思敏
作者单位:430033,中国湖北省武汉市第一医院眼科
摘    要:目的:观察视网膜静脉阻塞( retinal vein occlusion,RVO)黄斑水肿患者雷珠单抗治疗后脉络膜厚度的变化。
  方法:RVO黄斑水肿患者36例36眼行雷珠单抗3+prn次玻璃体腔注射治疗。随访1a,观察患眼及对侧眼治疗前和治疗后中心凹下脉络膜厚度的变化。
  结果:治疗前、治疗后1,6,12 mo时患眼平均中心凹下脉络膜厚度( Subfoveal choroidal thickness,SFCT)分别为246.7±115.0,220.5±102.0,198.3±114.0,212.6±96.0μm,差异有统计学意义(P<0.05)。对侧眼平均SFCT分别为229.4±108.0,226.3±107.0,228.6±127.0,223.6±101.0μm,对侧眼治疗前后中心凹下脉络膜厚度的变化无差异。
  结论:RVO黄斑水肿患者雷珠单抗治疗后中心凹下脉络膜厚度明显降低。雷珠单抗玻璃体腔注射治疗可能影响脉络膜血流状态。

关 键 词:视网膜静脉阻塞  雷珠单抗  黄斑水肿  脉络膜厚度
收稿时间:2015/1/19 0:00:00
修稿时间:2015/3/25 0:00:00

Changes in subfoveal choroidal thickness after intravitreal injections of ranibizumab for macular edema secondary to retinal vein occlusion
Qi Zhang,Jie Feng,Pei-Feng Li,Yi Jin and Si-Min Chen.Changes in subfoveal choroidal thickness after intravitreal injections of ranibizumab for macular edema secondary to retinal vein occlusion[J].International Journal of Ophthalmology,2015,15(4):712-713.
Authors:Qi Zhang  Jie Feng  Pei-Feng Li  Yi Jin and Si-Min Chen
Institution:Department of Ophthalmology, the First Hospital of Wuhan, Wuhan 430033, Hubei Province, China;Department of Ophthalmology, the First Hospital of Wuhan, Wuhan 430033, Hubei Province, China;Department of Ophthalmology, the First Hospital of Wuhan, Wuhan 430033, Hubei Province, China;Department of Ophthalmology, the First Hospital of Wuhan, Wuhan 430033, Hubei Province, China;Department of Ophthalmology, the First Hospital of Wuhan, Wuhan 430033, Hubei Province, China
Abstract:
Keywords:retinal vein occlusion  ranibizumab  macular edema  subfoveal choroidal thickness
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《国际眼科杂志》浏览原始摘要信息
点击此处可从《国际眼科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号